News | January 08, 2009

New Clinical Studies Support Broader Use of CardioNet System for the Detection of Atrial Fibrillation

January 9, 2009 - CardioNet Inc. today announced the publication of two studies and the presentation of two abstracts that further support the broader use of the CardioNet System for the detection of atrial fibrillation (AF).

The studies demonstrate the CardioNet System’s ability to detect clinically significant AF events in patients following ischemic stroke or surgical AF ablation procedures. The CardioNet System allows the detection of any patients that relapse with AF events, both symptomatic and asymptomatic, therefore enabling the physician to prescribe additional treatment or drug therapy in cases where the AF has reoccurred.

The first study is titled “Atrial Fibrillation Detected by Mobile Cardiac Outpatient Telemetry in Cryptogenic TIA or Stroke,” authored by A.H. Tayal, M.D., Allegheny General Hospital, Comprehensive Stroke Center was published in the Nov. 18, 2008 issue of Neurology. The purpose of the study was to demonstrate the feasibility of detecting AF in patients with stroke of undetermined etiology through prolonged monitoring. The study concluded that the CardioNet System detected a high rate of AF (23 percent) in patients that have experienced a transient ischemic attack (TIA) or stroke for which the etiology was indeterminable through standard diagnostic evaluation methods.

“Our study showed that mobile cardiac outpatient telemetry had a high rate of AF detection, including asymptomatic and short events, which may be a biomarker of prolonged and clinically significant AF.” said Dr. Tayal. “Such patients may benefit from anticoagulation and may not have been diagnosed with AF through standard methods.”

Evelio Rodriguez, M.D., division of cardiothoracic and vascular surgery, Brody School of Medicine, East Carolina University, presented an abstract from a study titled “Cryo-Maze for Concomitant Atrial Fibrillation: Mid-Term Results using CardioNet Home Monitoring Testing” at the 46th Annual Meeting of the Pennsylvania Association of Thoracic Surgeons Oct. 3, 2008. The study utilized the CardioNet System for home monitoring of patients that underwent concomitant AF ablation to determine the efficacy of the procedure. The authors of the study noted that rhythm assessment after ablation with electrocardiogram (ECG) and/or Holter monitors has been shown to overestimate success, which led to their selection of the CardioNet System for the study. The study concluded that home monitoring with the CardioNet System should become standard of care after interventions performed to restore sinus rhythm in patients with AF.

Two additional studies utilized the CardioNet System for post-operative management and follow-up of patients that underwent surgical procedures to treat AF:

- “Toward a Definitive, Totally Thoracoscopic Procedure for Atrial Fibrillation” - authored by John Sirak, M.D., Ohio State University Department of Surgery, division of cardiothoracic surgery, Columbus, OH, published in the Dec. 8, 2008 issue of The Annals of Thoracic Surgery.

- “Surgical Correction Of Atrial Fibrillation With The Cryomaze Procedure: Long-term Outcomes Assessed With Continuous Outpatient Telemetry” - abstract presented by James Gammie, M.D., University of Maryland Medical Center, at the Southern Thoracic Surgical Association 55th Annual Meeting on Nov. 6, 2008.

To date there have been 19 published clinical papers and abstracts on the capabilities and efficacy of the CardioNet System. This includes the landmark study that demonstrated the CardioNet System to be nearly three times better in diagnosing clinically significant arrhythmias as compared to loop event monitoring.

For more information:

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients
News | Heart Failure| July 14, 2017
A review appearing in the July 18 issue of the Journal of the American College of Cardiology (JACC) discusses current...
monitoring a heart failure patient's chest fluid buildup with remote monitoring using the SensiVest

A heart failure patient wearing the SensiVest remote monitoring system for a two-minute a day assessment. 

News | Heart Failure| July 13, 2017
July 13, 2017 — About 5.7 million adults in the U.S.
Sponsored Content | Videos | Heart Failure| July 13, 2017
William Abraham, M.D., director of the Division of Cardiovascular Medicine at The Ohio State University Wexner Medica
First Canadian Patient Implanted With CardioMEMS Heart Failure Sensor
News | Heart Failure| June 23, 2017
In a Canadian first, a medical team has implanted the wireless CardioMEMS HF device inside a heart failure patient. The...
Northwell Health Partners With Peerbridge Health on Remote Patient Monitoring
News | Wearable Sensors| June 01, 2017
Northwell Health recently announced a new partnership agreement with Peerbridge Health Inc., to explore the future of...
Biotronik Home Monitoring implanted EP device remote wireless monitoring system
News | May 24, 2017
May 23, 2017 – Results now published in the European Heart Journal show Biotronik Home Monitoring reduces th
Overlay Init